199 related articles for article (PubMed ID: 6199817)
1. [Development and current perspectives of treatment in multiple myeloma].
Sanz Marca A; López Alvarez J; Aboin Massieu FJ
Rev Clin Esp; 1983 Nov; 171(3):225-9. PubMed ID: 6199817
[No Abstract] [Full Text] [Related]
2. Supportive therapies in the management of myeloma.
Ludwig H;
Oncology (Williston Park); 2004 Mar; 18(3):295-6, 298. PubMed ID: 15065700
[No Abstract] [Full Text] [Related]
3. [Interferon: a new weapon in the therapeutic strategy of multiple myeloma].
Avvisati G; Petrucci MT; Mandelli F
Haematologica; 1990; 75 Suppl 4():68-71. PubMed ID: 1705913
[No Abstract] [Full Text] [Related]
4. [Current therapy concepts in patients with multiple myeloma].
Heyll A; Schneider P; Bauser U; Kobbe G; Hünerlitürkoglu A; Aul C; Haas R
Dtsch Med Wochenschr; 2000 Oct; 125(40):1201-9. PubMed ID: 11075253
[No Abstract] [Full Text] [Related]
5. Myeloma (multiple).
Kumar A; Djulbegovic B
Clin Evid; 2006 Jun; (15):1-29. PubMed ID: 16973003
[No Abstract] [Full Text] [Related]
6. Treatment of multiple myeloma and arterial thrombosis.
Raven W; Berghout A; van Houten A; Leebeek FW
Ann Hematol; 2010 Apr; 89(4):419-20. PubMed ID: 19688212
[No Abstract] [Full Text] [Related]
7. Management of multiple myeloma.
Richards JD; Singer CR; Tobias JS
Br J Hosp Med; 1987 May; 37(5):437, 440-2. PubMed ID: 2437986
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic strategies and controversies in the treatment of multiple myeloma.
Bladé J
Pathol Biol (Paris); 1999 Feb; 47(2):192-8. PubMed ID: 10192888
[TBL] [Abstract][Full Text] [Related]
9. [Multiple myeloma--advances in disease biology and implications for therapy].
Chou T
Gan To Kagaku Ryoho; 2001 Sep; 28(9):1206-12. PubMed ID: 11579631
[TBL] [Abstract][Full Text] [Related]
10. Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT.
Pitini V; Arrigo C; Aloi G; Micali C; La Gattuta G
Bone Marrow Transplant; 2003 Jun; 31(11):1065; author reply 1067. PubMed ID: 12774062
[No Abstract] [Full Text] [Related]
11. Development of targeted therapies for B-cell non-Hodgkin lymphoma and multiple myeloma.
Hernandez-Ilizaliturri FJ; Gowda A; Czuczman MS
Clin Adv Hematol Oncol; 2004 Sep; 2(9):606-18. PubMed ID: 16163245
[TBL] [Abstract][Full Text] [Related]
12. Current clinical and laboratory strategies to augment the efficacy of immunotherapy in multiple myeloma.
Gorschlüter M; Ziske C; Glasmacher A; Schmidt-Wolf IG
Clin Cancer Res; 2001 Aug; 7(8):2195-204. PubMed ID: 11489792
[TBL] [Abstract][Full Text] [Related]
13. The refractory patient: new treatment options.
Schuster MW
Oncology (Williston Park); 2003 Oct; 17(10):1333-5. PubMed ID: 14606360
[No Abstract] [Full Text] [Related]
14. [Results, failures and perspectives in therapy of multiple myeloma].
Bessmel'tsev SS; Abdulkadyrov KM
Vopr Onkol; 2002; 48(2):146-52. PubMed ID: 12227061
[No Abstract] [Full Text] [Related]
15. Lenalidomide and its role in the management of multiple myeloma.
Falco P; Cavallo F; Larocca A; Liberati AM; Musto P; Boccadoro M; Palumbo A
Expert Rev Anticancer Ther; 2008 Jun; 8(6):865-74. PubMed ID: 18533796
[TBL] [Abstract][Full Text] [Related]
16. [Therapy of multiple myeloma].
La Verde G; Pulsoni A; Petrucci MT; Mandelli F
Recenti Prog Med; 1997 Apr; 88(4):186-93. PubMed ID: 9206817
[TBL] [Abstract][Full Text] [Related]
17. [High-dose melphalan in patients with multiple myeloma].
Moreau P; Le Bonniec M; Harousseau JL
Bull Cancer; 1999 Mar; 86(3):283-8. PubMed ID: 10210762
[TBL] [Abstract][Full Text] [Related]
18. [Comparative evaluation of the effectiveness of mono- and polychemotherapy programs in patients with multiple myeloma].
Abdulkadyrov KM; Bessmel'tsev SS
Klin Med (Mosk); 1992; 70(9-10):57-60. PubMed ID: 1474818
[No Abstract] [Full Text] [Related]
19. Rapid complete remission in multiple myeloma with bortezomib/thalidomide/dexamethasone combination therapy following development of tumor lysis syndrome.
Chim CS
Cancer Chemother Pharmacol; 2008 Jun; 62(1):181-2. PubMed ID: 17846773
[No Abstract] [Full Text] [Related]
20. [Skeletal bone lesion and the effectiveness of Bonephos (clodronate) in the comprehensive therapy of multiple myeloma].
Bessmel'tsev SS; Abdulkadyrov KM
Vopr Onkol; 1996; 42(4):12-8. PubMed ID: 8928450
[No Abstract] [Full Text] [Related]
[Next] [New Search]
